Use of (x-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reutake and new compounds for this use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 18, 1998
Grant Date -
N/A
app pub date -
May 17, 1996
filing date -
May 19, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to the use of a compound selected from: ?.alpha.-(tert-butylaminomethyl)-3,4-dichlorobenzyl!thioacetamide and its laevorotatory isomer, ?.alpha.-(tert-amylaminomethyl)-3,4-dichlorobenzyl!thioacetamide and its isomers, ?.alpha.-(1-adamantylaminomethyl)3,4-dichlorobenzyl!thioacetamide and its isomers, as well as the addition salts of these compounds with pharmaceutically acceptable acids, for inhibiting dopamine reuptake.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully